Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RCUS |
---|---|---|
09:32 ET | 8487 | 15.63 |
09:33 ET | 2000 | 15.9 |
09:35 ET | 100 | 15.88 |
09:37 ET | 400 | 15.79 |
09:39 ET | 350 | 15.9 |
09:42 ET | 250 | 15.955 |
09:44 ET | 750 | 16.11 |
09:46 ET | 900 | 16.075 |
09:48 ET | 400 | 16.1 |
09:53 ET | 3096 | 16.1275 |
09:55 ET | 339 | 16.23 |
09:57 ET | 2323 | 15.94 |
10:02 ET | 500 | 15.975 |
10:04 ET | 2102 | 16.09 |
10:06 ET | 100 | 16.06 |
10:08 ET | 980 | 16.1 |
10:09 ET | 2014 | 15.92 |
10:11 ET | 2206 | 15.925 |
10:13 ET | 4683 | 15.93 |
10:15 ET | 500 | 15.915 |
10:18 ET | 10434 | 15.92 |
10:20 ET | 900 | 15.915 |
10:22 ET | 1867 | 15.955 |
10:24 ET | 6938 | 15.995 |
10:26 ET | 9969 | 16 |
10:27 ET | 1408 | 15.97 |
10:29 ET | 2285 | 16.16 |
10:31 ET | 1706 | 16.085 |
10:33 ET | 1446 | 16.08 |
10:36 ET | 807 | 16.025 |
10:38 ET | 600 | 16.02 |
10:40 ET | 1110 | 16.06 |
10:42 ET | 500 | 16.09 |
10:44 ET | 695 | 16.12 |
10:45 ET | 1425 | 16.135 |
10:47 ET | 1400 | 16.19 |
10:49 ET | 8072 | 16.255 |
10:51 ET | 584 | 16.32 |
10:54 ET | 1600 | 16.33 |
10:56 ET | 1319 | 16.36 |
10:58 ET | 200 | 16.36 |
11:00 ET | 300 | 16.3016 |
11:02 ET | 667 | 16.37 |
11:03 ET | 200 | 16.37 |
11:05 ET | 2244 | 16.345 |
11:07 ET | 400 | 16.34 |
11:12 ET | 500 | 16.34 |
11:14 ET | 200 | 16.34 |
11:16 ET | 500 | 16.38 |
11:18 ET | 7494 | 16.435 |
11:20 ET | 1605 | 16.37 |
11:21 ET | 1084 | 16.33 |
11:23 ET | 100 | 16.325 |
11:25 ET | 250 | 16.3285 |
11:30 ET | 247 | 16.36 |
11:32 ET | 2553 | 16.3 |
11:34 ET | 1956 | 16.31 |
11:36 ET | 2134 | 16.31 |
11:38 ET | 3753 | 16.295 |
11:39 ET | 100 | 16.32 |
11:41 ET | 100 | 16.34 |
11:45 ET | 2456 | 16.365 |
11:48 ET | 450 | 16.42 |
11:50 ET | 849 | 16.45 |
11:52 ET | 300 | 16.45 |
11:54 ET | 400 | 16.46 |
11:56 ET | 300 | 16.47 |
11:57 ET | 400 | 16.435 |
11:59 ET | 3179 | 16.33 |
12:01 ET | 200 | 16.34 |
12:03 ET | 1400 | 16.3 |
12:06 ET | 800 | 16.325 |
12:08 ET | 3042 | 16.34 |
12:10 ET | 871 | 16.33 |
12:12 ET | 1258 | 16.25 |
12:14 ET | 1205 | 16.235 |
12:15 ET | 660 | 16.235 |
12:19 ET | 1143 | 16.26 |
12:21 ET | 500 | 16.25 |
12:24 ET | 400 | 16.275 |
12:26 ET | 100 | 16.275 |
12:28 ET | 100 | 16.28 |
12:30 ET | 1797 | 16.29 |
12:32 ET | 2347 | 16.38 |
12:33 ET | 4368 | 16.41 |
12:35 ET | 100 | 16.4 |
12:37 ET | 2006 | 16.42 |
12:39 ET | 1989 | 16.39 |
12:42 ET | 1628 | 16.4 |
12:44 ET | 100 | 16.395 |
12:48 ET | 1942 | 16.45 |
12:50 ET | 100 | 16.46 |
12:51 ET | 6562 | 16.38 |
12:53 ET | 311 | 16.375 |
12:55 ET | 250 | 16.375 |
12:57 ET | 2351 | 16.44 |
01:00 ET | 300 | 16.41 |
01:04 ET | 100 | 16.4 |
01:08 ET | 1128 | 16.42 |
01:09 ET | 2597 | 16.41 |
01:11 ET | 118800 | 16.43 |
01:18 ET | 11838 | 16.63 |
01:20 ET | 400 | 16.605 |
01:22 ET | 1622 | 16.62 |
01:24 ET | 200 | 16.595 |
01:26 ET | 137 | 16.595 |
01:27 ET | 2574 | 16.5506 |
01:31 ET | 1206 | 16.55 |
01:33 ET | 216 | 16.53 |
01:36 ET | 1532 | 16.475 |
01:38 ET | 900 | 16.53 |
01:40 ET | 500 | 16.51 |
01:42 ET | 824 | 16.47 |
01:51 ET | 100 | 16.435 |
01:54 ET | 207 | 16.41 |
01:56 ET | 381 | 16.4 |
01:58 ET | 988 | 16.425 |
02:00 ET | 361 | 16.425 |
02:02 ET | 1968 | 16.36 |
02:03 ET | 1631 | 16.33 |
02:05 ET | 1951 | 16.465 |
02:09 ET | 700 | 16.465 |
02:12 ET | 100 | 16.45 |
02:14 ET | 200 | 16.44 |
02:16 ET | 1099 | 16.46 |
02:18 ET | 100 | 16.48 |
02:20 ET | 300 | 16.42 |
02:21 ET | 900 | 16.44 |
02:23 ET | 100 | 16.47 |
02:25 ET | 200 | 16.45 |
02:27 ET | 100 | 16.47 |
02:30 ET | 1644 | 16.47 |
02:32 ET | 440 | 16.47 |
02:34 ET | 200 | 16.475 |
02:36 ET | 800 | 16.45 |
02:38 ET | 200 | 16.46 |
02:39 ET | 300 | 16.49 |
02:41 ET | 300 | 16.49 |
02:45 ET | 740 | 16.49 |
02:48 ET | 771 | 16.48 |
02:50 ET | 497 | 16.4842 |
02:52 ET | 225 | 16.5 |
02:54 ET | 18302 | 16.39 |
02:56 ET | 1174 | 16.38 |
02:57 ET | 200 | 16.35 |
02:59 ET | 430 | 16.365 |
03:01 ET | 4465 | 16.45 |
03:03 ET | 800 | 16.44 |
03:06 ET | 1839 | 16.49 |
03:08 ET | 700 | 16.49 |
03:10 ET | 500 | 16.485 |
03:12 ET | 1664 | 16.534 |
03:14 ET | 300 | 16.51 |
03:15 ET | 417 | 16.47 |
03:17 ET | 1300 | 16.445 |
03:19 ET | 2100 | 16.43 |
03:21 ET | 2904 | 16.36 |
03:24 ET | 4319 | 16.43 |
03:26 ET | 1452 | 16.45 |
03:28 ET | 600 | 16.46 |
03:30 ET | 1235 | 16.435 |
03:32 ET | 1200 | 16.44 |
03:33 ET | 100 | 16.456 |
03:35 ET | 3033 | 16.445 |
03:37 ET | 1392 | 16.476 |
03:39 ET | 2037 | 16.47 |
03:42 ET | 1250 | 16.48 |
03:44 ET | 2158 | 16.5025 |
03:46 ET | 2575 | 16.54 |
03:48 ET | 2435 | 16.52 |
03:50 ET | 6035 | 16.485 |
03:51 ET | 3829 | 16.47 |
03:53 ET | 7531 | 16.45 |
03:55 ET | 3760 | 16.515 |
03:57 ET | 14145 | 16.44 |
04:00 ET | 127592 | 16.44 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Arcus Biosciences Inc | 1.5B | -5.2x | --- |
Ardelyx Inc | 1.3B | -17.7x | --- |
Nurix Therapeutics Inc | 1.5B | -7.2x | --- |
Travere Therapeutics Inc | 1.7B | -4.3x | --- |
Arvinas Inc | 1.7B | -5.0x | --- |
Arcutis Biotherapeutics Inc | 1.4B | -6.9x | --- |
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company involves in a portfolio of investigational products, which are in clinical development with its advanced molecule, an anti-TIGIT antibody targeting lung and gastrointestinal cancers. The Company has approximately seven clinical programs that are focused on targets, including TIGIT, PD-1, adenosine A2a and A2b receptors, CD73, CD39, HIF-2a, and AXL. The Company is engaged in co-developing four investigational products, including zimberelimab (Arcuss anti-PD-1 molecule), domvanalimab (Arcuss anti-TIGIT antibody), etrumadenant (Arcuss adenosine receptor antagonist) and quemliclustat (Arcuss CD73 inhibitor). It is engaged in pursuing a Phase II and Phase III development program for domvanalimab in combination with its anti-PD-1 antibody, zimberelimab, in multiple settings, including lung and gastrointestinal cancer.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.5B |
---|---|
Revenue (TTM) | $263.0M |
Shares Outstanding | 91.5M |
Arcus Biosciences Inc does not pay a dividend. | |
Beta | 0.85 |
EPS | $-3.15 |
Book Value | $6.12 |
P/E Ratio | -5.2x |
Price/Sales (TTM) | 5.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -120.91% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.